Table 2.

Characteristics of subjects with prediabetes and T2DM, diagnosed at the follow-up visit.

	Healthy	IFG	IGT	T2DM
N/%	93/45.6%	78/37.7%	19/9.3%	16/7.4%
Age [years]	42 ± 1.61	49 ± 1.55 (p < 0.03)	56 ± 2.20 (p < 0.01)	56 ± 3.03 (p < 0.01)
BMI [kg/m²]	25.70 ± 0.54	29.51 ± 0.84 p < 0.01	30.73 ± 1.38 p = 0.03	34.46 ± 2.59 p = 0.02
Waist circumference [cm]	88.21 ± 1.52	100.42 ± 1.94 p < 0.01	103.33 ± 3.43 p = 0.02	113.53 ± 6.27 p < 0.01
Hip circumference [cm]	95.67 ± 1.12	104.75 ± 1.49 p < 0.01	109.11 ± 2.54 p < 0.01	114.60 ± 4.89 p < 0.01
Muscle mass [%]	35.35 ± 0.61	31.78 ± 0.69 p = 0.02	28.61 ± 0.99 p < 0.01	28.74 ± 2.03 p = 0.03
Subcutaneous fat [%]	76.12 ± 0.74	70.21 ± 0.89 p < 0.01	68.83 ± 1.95 p = 0.06	64.25 ± 2.94 p < 0.01
Visceral fat [%]	23.80 ± 0.74	29.78 ± 0.89 p < 0.01	31.15 ± 1.95 p = 0.06	35.80 ± 2.96 p < 0.01
VAT/SAT ratio	0.30 ± 0.01	0.44 ± 0.02 p < 0.01	0.48 ± 0.05 p = 0.06	0.62 ± 0.09 p < 0.01
HOMA-IR index	2.38 ± 0.11	3.95 ± 0.25 p < 0.01	4.03 ± 0.44 p = 0.02	7.05 ± 1.23 p < 0.01

VAT/SAT ratio—visceral adipose tissue/subcutaneous adipose tissue ratio; HOMA-IR—homeostatic model assessment estimated insulin resistance; BMI—body mass index.